That depends on market conditions. If the stock performs well during the next two months and the IDIX presentations at EASL generate a buzz, I would think a small financing transaction might be in order around that time. The degree to which IDIX receives IDX899 milestone payments from GSK during 1H10 will also be a factor (#msg-45620605).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”